JAGSONPAL PHARMACEUTICALS
Back to Balance Sheet
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Total Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹226 Cr | ₹203 Cr | ₹171 Cr | ₹164 Cr | ₹149 Cr |
What is the latest Total Liabilities ratio of JAGSONPAL PHARMACEUTICALS ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹226 Cr |
Mar2023 | ₹203 Cr |
Mar2022 | ₹171 Cr |
Mar2021 | ₹164 Cr |
Mar2020 | ₹149 Cr |
How is Total Liabilities of JAGSONPAL PHARMACEUTICALS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹226 Cr | 11.37 | |
Mar2023 | ₹203 Cr | 18.18 | |
Mar2022 | ₹171 Cr | 4.38 | |
Mar2021 | ₹164 Cr | 10.43 | |
Mar2020 | ₹149 Cr | - |
Compare Total Liabilities of peers of JAGSONPAL PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JAGSONPAL PHARMACEUTICALS | ₹1,638.2 Cr | 7.2% | 9.6% | 71% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,091.0 Cr | 2.3% | 3.2% | 9.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,302.0 Cr | -0.2% | 4.5% | 49.6% | Stock Analytics | |
CIPLA | ₹119,038.0 Cr | -0.2% | -2% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹117,170.0 Cr | 3.7% | 6.5% | 16.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,061.0 Cr | -0% | -4.6% | -6.2% | Stock Analytics |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JAGSONPAL PHARMACEUTICALS | 7.2% |
9.6% |
71% |
SENSEX | -1.1% |
1% |
3.4% |
You may also like the below Video Courses